Bridging the gap between
Raw Intelligence and Professional Trust
The challenge isn't generating answers—it's validating them. ConsultFlow solves the adoption gap by anchoring automated insights in expert-verified feedback loops.
Intelligent Assistant. Expert Control.
Watch how ConsultFlow bridges the gap between unstructured user needs and rigorous professional standards. This architecture powers verified outcomes across any high-stakes domain.
Turn Expertise into Output
AI handles the first-pass drafting and research aggregation so you can spend time on decisions and nuance.
- Smarter Iteration Ask questions, revise sections, and converge on a final report in fewer passes.
- Trustable References Audit curated knowledge and external sources in one place to support what you sign.
Clinic Case Intake (Auto‑Prefill)
Clinic staff can submit a case without filling every field—our AI understands uploaded documents and pre-fills the intake with rationale. Staff just verifies and updates if needed.
Vet Flow Assistant
Answers low-acuity consultation requests with high quality, reducing wait time for basic guidance—escalating only when expert review is needed.
Curated skills the AI must cite
We partner with clients to build domain knowledge skills (e.g. Veterinary Oncology), then feed them into the AI so outputs stay grounded and auditable.
# Mast Cell Tumors Mast cell tumors are comprised of mast cells, which are immune cells normally involved in allergic reactions. They are the same cells that cause the itchy, red bump you get after a mosquito bite or the more serious reactions that occur in people allergic to peanuts or shellfish. Mast cells contain granules packed with chemicals including histamine. The release of chemicals from granules leads to allergic reactions. Mast cell tumors occur most frequently in the skin, but other sites include the liver, spleen, gastrointestinal tract and bone marrow. Mast cell tumors vary in appearance. Some may look like raised bumps within, or just below the surface of, the skin. Others appear as red, ulcerated, bleeding, bruised, and/or swollen growths. Some tumors appear and remain the same size for months or years, while others show a rapid growth pattern over days or weeks. They can also increase and decrease in size over time. Tumors can be irritating and dogs will scratch, lick, or bite the mass and surrounding skin. This trauma causes the tumor cells to release the chemicals in their granules leading to a localized reaction. In more serious cases, the chemicals can affect the entire body, causing severe gastrointestinal bleeding and even an anaphylactic reaction, which can be fatal if untreated. Mast cell tumors occur more frequently in retriever breeds and brachycephalic (flat-faced) breeds (Boxers, Boston Terriers, Pugs, and Bulldogs) but any breed can be affected. --- # What are the clinical signs? The behavior of mast cell tumors is unpredictable. Many affected dogs have no signs other than the presence of the tumor. Other signs include scratching or biting at a skin mass, vomiting, diarrhea, bloody stool, lethargy, and/or decreased appetite. More severe signs are usually associated with a larger disease burden (e.g. internal spread). The most common locations of spread (metastasis) are local lymph nodes, liver, and spleen. --- # What diagnostics are performed? A diagnosis can never be made from just observing the physical appearance or consistency of skin growth. Confirmation of the diagnosis is usually done with a simple needle aspirate of the tumor. Additional diagnostics include a sampling of local lymph nodes, abdominal ultrasound (+/- aspirates of liver and spleen), and bone marrow cytology. Biopsy with wide surgical excision is recommended to determine the grade of the tumor. For tumors located internally, the diagnosis can be more challenging. An ultrasound or CT scan may be required to visualize the mass. In many cases, an aspirate of the tumor can confirm the diagnosis, but a more invasive procedure (e.g. surgery) may be required to achieve a definitive answer. A concurrent overall health evaluation includes a thorough physical exam (some dogs can have multiple skin tumors at the time of diagnosis), bloodwork, and urinalysis. Learn more about Cancer Staging tests here. --- # Treatment options available and prognosis: Surgical removal is recommended for most skin mast cell tumors. This is true for dogs presenting with multiple tumors or dogs who develop more than one mast cell tumor over time. The tumor must be submitted to a pathologist for evaluation of two critical pieces of information: the grade of the tumor and whether or not the tumor was removed completely. Tumor grade is reported as either low or high, a numerical value (e.g. grade I, grade II, or grade III), or most commonly both. High-grade/grade III tumors are more aggressive, with higher rates of regrowth after removal and a higher chance of spread (metastasis). On the other hand, surgery alone can be curative for low-grade/grade I tumors. Grade II tumors can be either high or low-grade and are our biggest therapeutic challenge. For most tumors, regardless of grade, additional therapy is recommended if the initial surgery was unsuccessful in removing the entire tumor. Options include a second surgery or radiation therapy. Chemotherapy can be used instead of surgery and/or radiation therapy to limit regrowth of an incompletely removed tumor, but the efficacy can be low. Chemotherapy plays a bigger role in preventing or delaying spread from the original tumor and is recommended for cases with documented metastasis (regardless of grade), for high-grade/grade III tumors, and for some grade II tumors. Chemotherapy is also used for dogs diagnosed with a primary tumor of an internal organ (e.g. spleen or gastrointestinal tract.) The prognosis for skin mast cell tumors is variable and depends on the grade, extent of disease (stage), as well as the ability to achieve adequate local control of the primary tumor. Metastasis, especially beyond a single local lymph node, indicates a more aggressive clinical course and cure is not usually possible. Dogs with spread to only the local lymph node may not have a worse prognosis if both the affected lymph node and the primary tumor are adequately removed. Tumors that arise primarily in the gastrointestinal tract, liver, or spleen carry a guarded prognosis and an aggressive clinical course is expected. The prognosis is typically only a few months. Regardless of your treatment plan, several medications are recommended to prevent side effects from tumor-related inflammation and release of chemicals from cells, which can lead to gastrointestinal ulceration. This includes antihistamines (diphenhydramine/Benadryl), antacids (famotidine/Pepcid or omeprazole/ Prilosec), and corticosteroids (prednisone). Dogs that develop one skin mast cell tumor are at risk for developing future mast cell tumors. These new tumors most commonly arise on their own rather than being related to any previous ones (i.e., they did not spread from a previously removed tumor). Dogs with multiple skin mast cell tumors may not have a worse prognosis than a dog with one if they are all low grade and can all be adequately removed. Active surveillance for any new lump or bump is essential in such cases, and early evaluation is recommended any dog with a skin mass. --- # What are the side effects? Side effects are associated with the treatment selected and the extent of disease and clinical signs. Recovery from anesthesia and brief hospitalization is required with any surgical procedure and risks include those associated with any form of anesthesia and surgery. Radiation therapy also includes the use of anesthesia and side effects depend on the area undergoing treatment. For skin tumors, localized redness and irritation is possible. If the radiation field were to encompass any internal organs, side effects can include temporary gastrointestinal upset (among other signs). Side effects of chemotherapy are infrequent and most commonly include temporary mild gastrointestinal upset such as vomiting or diarrhea. Decreased appetite and lethargy may also occur. Your pet will be prescribed supportive medications for nausea (should decreased appetite, or increased salivation, or drooling occur) and diarrhea for you to have on hand at home to use if necessary. It is best to be proactive with these medications and provide these as soon as signs are noted. Individual chemotherapy drugs also have the potential for their own specific side effects which your pet’s oncologist will discuss with you. The most common side effects from steroid therapy include increased urination, thirst, and hunger. Steroid doses are typically adjusted over time to reduce these effects. Other potential side effects include gastrointestinal upset (vomiting, diarrhea, dark or reddened stool associated with gastrointestinal bleeding) and systemic effects on the liver and kidneys. Blood work is used for monitoring and supportive medications can be provided to assist if side effects develop. Should you have any questions, your oncology team is available to assist. --- # Concerns of chemotherapy for my pet? Chemotherapy often carries a negative impression, especially with our understanding of chemotherapy in human medicine. Our approach to chemotherapy in veterinary medicine is focused on limiting severe side effects and providing increased quality of life. Chemotherapy in human medicine is provided with the intent to cure by using very high doses which often result in increased side effects. As quality of life is imperative for our pets, doses are adjusted and your pet is monitored to limit severe side effects. Hair loss is rare except in certain breeds such as poodles. The majority of pets tolerate chemotherapy very well and are able to enjoy their normal lifestyle. However, there is a small percentage who have significant side effects with rare cases that require hospitalization. Whenever a pet does not tolerate chemotherapy well we are typically able to successfully adjust the dose and supportive medications to avoid such side effects in the future. Should you have concerns during therapy, speak with your oncologist in order to develop a tailored plan for your pet. --- # How do I prepare? We understand this is a difficult time and we are here to support you and your pet by providing the options and care necessary. Selecting a therapy is not binding and can be adjusted to you and your pet’s needs. During treatment sessions, you will be provided with updates and any recommendations depending on your pet’s response. Should any concerns arise, your oncology team will provide answers and help to guide you. --- ## Treatment Summary | Treatment | Indication | Treatment Schedule | Cost | |---------|------------|-------------------|------| | Surgery | Solitary tumors, multiple cutaneous tumors, +/- regional lymph node metastases | Pending further evaluation | ~ $4,000 - $6,000 | | Radiation Therapy Definitive (post- operative) | Incompletely excised tumors | Daily treatments for 3 - 4 weeks | $8,000-$10,000 | | Radiation Therapy Palliative | Non-resectable tumors | Varies | ~$1,500 - $5,000 | | Chemotherapy: Vinblastine, Lomustine | High grade tumors, tumors with documented metastases, non- resectable tumors | IV and/or oral chemotherapy every one to three weeks | $600 - $700 per treatment | | Chemotherapy: Tyrosine Kinase Inhibitors (Palladia) | High grade tumors, tumors with documented metastases, non- resectable tumors | Oral medication given at home every other day or three times per week | $400 - $700 per month (depending on pet’s weight) | | Steroids | Typically palliative | Oral medication daily with intermittent bloodwork for monitoring | $30 - $250 per month (if labwork done here) | Cost estimates are based on individual appointments and overall cost is dependent on patient response and does not include additional supportive care or hospitalization, if required.
# Cancer Staging Owners are often curious as to what stage of cancer their pet has without understanding what the term ‘stage’ truly means. Stage refers to where in the body we find evidence of cancer. In human medicine, the World Health Organization (WHO) establishes guidelines for cancer staging. We modify these guidelines for veterinary patients. Most tumors are staged numerically, using Roman numerals 0 – IV. In general, the higher the number the more the cancer has spread. Some cancers use different schemes (e.g. canine lymphoma is staged I-V.) Other tumor types do not have staging schemes (e.g. brain cancers.) Staging tests determine the extent of the local disease and look for evidence of spread (metastasis) of cancer. The extent of testing depends on the predicted behavior of the tumor. We also consider the goals, resources, and expectations of the pet owner. The most common sites of metastasis are the lungs and lymph nodes. We evaluate the lungs using radiographs (x-rays) or a CT scan. Lymph nodes are tested by sampling cells and looking at them under a microscope. Tumors can spread to any location in the body, however. Therefore, additional tests including abdominal ultrasound or CT scan, MRI, bone marrow sampling, or even a bone scan may be discussed. Bloodwork rarely provides information regarding stage, except in cases of cancers that start in the blood or bone marrow. Bloodwork is important to assess the overall health status of the pet. This helps us decide on the best diagnostic and treatment plan for each pet. Other terms your oncologist may use to describe your pet’s stage of disease include: - **Local or localized disease:** Cancer is confined to one organ or structure. - **Locally advanced or loco-regional disease:** Cancer is metastatic to a local lymph node and/or is locally invasive within the surrounding tissues. - **Distant or advanced:** Cancer has metastasized beyond the local lymph node. Staging is important for several reasons - It allows for appropriate treatment planning. - It can help gauge prognosis. - It evaluates the general health of the patient. - It is a common “language” that veterinarians can use to compare patients and their outcomes Several key points regarding staging are - In order to accurately assign a stage of disease, pets must undergo all recommended diagnostic tests. For example, to completely stage a dog with lymphoma, we need to do the following diagnostics: Physical exam, complete blood count with pathology review, lymph node biopsy, three view thoracic radiographs or thoracic CT scan, abdominal ultrasound or abdominal CT scan with sampling of the liver and spleen, and bone marrow aspirate. If any test is skipped, we can’t definitively state the dog’s stage. - While the size of a tumor can influence stage for some cancers, we must consider tumor size in relation to the size of the pet. For example, dogs with oral melanoma tumors <2cm in size have a better prognosis than dogs with tumors ≥ 2cm. However, we must consider how much our canine patients vary in size. A 2cm oral tumor in a 130lb Great Dane would not cause as much trouble eating and drinking as a 2cm oral tumor in a 7lb chihuahua. Despite data suggesting both the Great Dane and chihuahua have the same prognosis, the smaller dog will have greater complications from the same sized mass. - A cancer’s stage does not change. The stage of disease is determined only when the cancer is initially diagnosed. If the cancer shrinks, grows, spreads, or recurs the disease is still referred to as the stage it was given when it was first diagnosed. - Stage is more than a number. Many people assume the higher the number the worse the prognosis, regardless of disease. While usually true within a specific type of cancer, the numerical stage of one cancer cannot be compared to different cancer. For example, a dog stage 3 splenic hemangiosarcoma has a worse prognosis than a dog with stage 5 lymphoma. - Restaging refers to repeating staging tests during and/or after treatment. The frequency of restaging varies with the tumor type and treatment plan. In general, repeat staging for pets receiving chemotherapy is done every 2-3 treatments. We want to ensure that the treatment is successful and the cancer is not progressing despite our plan. If progression is seen, we can discuss what this means and alternative recommendations. For owners, knowing how advanced their pet’s disease is at the time of diagnosis allows them to make decisions about their care and to be realistic about their outcome. For clinicians, stage can influence treatment decisions and prognosis. While stage is important, the overall health of the pet is the most important factor in this discussion. Your oncologist will review what tests are required and what tests can be omitted. Talk with your veterinarian about any questions or concerns you have about staging. Together you will come up with the best plan for you and your pet.
# Bone Tumors Bone tumors can arise directly from bone or may occur as a metastatic lesion from underlying cancer outside of the skeleton. The most common primary bone tumor in dogs is osteosarcoma. Other bone tumors include chondrosarcoma, fibrosarcoma, hemangiosarcoma, liposarcoma, histiocytic sarcoma, multiple myeloma, and metastatic tumors. Osteosarcoma tumors of the appendicular skeleton (long bones of the limbs) are locally invasive and have a high rate of metastases (most commonly lungs and other bones). Osteosarcoma tumors can also occur in the axial skeleton (the bones of the skull, spinal column, pelvis, and ribs). Tumors of these locations tend to have a decreased rate of metastasis compared to those of the limbs. It is important to differentiate osteosarcoma from other tumor types and diseases that occur within bones, such as bacterial, viral, or fungal infections. With infection, there is usually a history of exposure to the infectious agent or traumatic injury to the affected region. Identification of the underlying cause is important, as this will influence the recommended therapeutic regimen. --- # What are the clinical signs? Signs are nonspecific and depend on the site affected as well as the underlying cause. For tumors located on the limb, a history of lameness, discomfort, or intermittent limping is noted. A firm swelling can also be noted. X-rays of the affected site may be recommended at the onset of signs, or should they fail to resolve with conservative management. Other nonspecific clinical signs include discomfort (panting, inability to get comfortable), favoring other limbs, aggression, loss of appetite, weight loss, reduced exercise tolerance, and whimpering/crying out. --- # What diagnostics are performed? In order to diagnose bone disease, a physical exam, blood tests (CBC/Chemistry), and x-rays (of both the primary site and the lungs) are recommended. The physical examination allows identification of disease and establishes a baseline for future monitoring, while blood tests can reveal changes that affect prognosis in addition to assessing a patient’s overall health. X-rays evaluate for metastatic disease or establish a baseline for future monitoring. Biopsy or aspirate of the affected region of bone is frequently recommended to distinguish between cancerous and infectious processes. An abdominal ultrasound may be recommended to assess for an underlying primary tumor or other condition that could affect the outcome. These diagnostics assist in our ability to provide you with information regarding therapy and prognosis, in addition to assessing your pet’s general health. Learn more about Cancer Staging tests here. --- # What are the Treatment Options? Treatment options will depend on the results of the diagnostics performed. In cases of infection, systemic therapy including antibiotics, antifungal, or antiviral agents may provide sufficient therapy, though painful bone lesions still require amputation or surgical removal. For metastatic tumors, the nature of the primary tumor will guide further therapy. In the case of a primary bone tumor, therapy is based on the location and extent of disease. When determining therapy for primary bone tumors, several factors are considered including the dog’s physical condition (ability to ambulate, history of arthritis), potential for spread of disease (metastasis), prognostic factors (elevation in blood markers, most notably alkaline phosphatase), and the family’s goals for quality of life. --- ## Amputation For tumors of the limbs, amputation is most frequently recommended. Though amputation is an aggressive therapy, the majority of patients respond favorably to this procedure given the severe pain associated with the presence of the primary lesion. The risk of fracture is also eliminated. Limb-sparing procedures can be pursued should the location and features of the tumor be amenable to the procedure. Risks include fracture and infection. --- ## Stereotactic radiation Stereotactic radiation is another approach for some lesions as determined by diagnostic evaluation. This modality of treatment provides pain relief without requiring amputation, though the risk of fracture is possible. --- ## Chemotherapy Chemotherapy is recommended for many primary bone tumors, in conjunction with both surgery and/or radiation therapy. For osteosarcoma specifically, treatment includes administration of intravenous (IV) chemotherapy every few weeks for a set number of treatments with the goal of prolonging quality of life rather than cure. Prognosis with surgery and chemotherapy is estimated at 12-14 months with excellent pain control and quality of life. Prognosis with amputation alone is estimated at 4-5 months. If no amputation is pursued, the prognosis is similar, however, without intervention the pet’s quality of life is usually poor due to intractable pain. --- ## Surgery Primary bone tumors of the axial skeleton are usually assessed with a CT scan. Complete surgical removal may not be possible. If surgery is done, and microscopic tumor cells are left behind, the tumor is likely to recur at the same site and follow-up therapy with radiation will be recommended. Average survival is dependent on site and treatment pursued. The most common cause of treatment failure is local tumor recurrence and chemotherapy may be indicated based on completeness of resection, evaluation of tumor behavior, and extent of disease. --- ## Palliative Options Palliative options are available for dogs and are directed at alleviating pain and clinical signs. Options include oral medications and the administration of IV bone supportive medications called bisphosphonates. Radiation therapy may also provide pain relief and a course may be provided to this effect. --- # What are the side effects? Side effects are associated with the treatment modality selected. Recovery from anesthesia and brief hospitalization are required with any surgical procedure and risks include those associated with any form of anesthesia and surgery. Radiation therapy also includes the use of anesthesia during treatments with minimal side effects from the treatments directly. There is a risk of fracture in patients who undergo limb salvage procedures (e.g. limb-sparing surgery or radiation therapy). Side effects of chemotherapy are infrequent but can include temporary mild gastrointestinal upset such as vomiting or diarrhea. Decreased appetite and lethargy may also occur. Your pet will be prescribed supportive medications for nausea (should decreased appetite, or increased salivation, or drooling occur) and diarrhea for you to have on hand at home to use if necessary. It is best to be proactive with these medications and administer them as soon as signs are noted. Should you have any questions, your oncology team is available to assist. --- # Concerns of chemotherapy for my pet Chemotherapy often carries a negative impression, especially with our understanding of chemotherapy in human medicine. Our approach to chemotherapy in veterinary medicine is focused on limiting severe side effects and providing increased quality of life. Chemotherapy in human medicine is provided with the intent to cure by using very high doses and increased side effects. As quality of life is imperative for our pets, doses are adjusted and your pet is monitored to limit severe side effects. Hair loss is rare except in certain breeds such as poodles. Though there is a slight risk of hospitalization in our pet population and mild gastrointestinal upset, the majority of pets tolerate therapy well. Should you have concerns during therapy, speak with your oncologist in order to develop a tailored plan for your pet. --- # How do I prepare? We understand this is a difficult time and we are here to support you and your pet by providing the options and care necessary. Selecting a therapy is not binding and can be adjusted to you and your pet’s needs. During treatment sessions, you will be provided with updates and any recommendations depending on your pet’s response. Should any concerns arise, your oncology team will provide answers and help to guide you. --- # Navigating through my options | Treatment | Prognosis - (median) | Treatment schedule | Approximate cost* | |----------|----------------------|--------------------|------------------| | Amputation alone | 4 - 6 months | Scheduled procedure. | $5,000 - $8,000 | | Amputation and chemotherapy | 12 - 14 months | IV chemotherapy once every 3 weeks, starting ~2 weeks after surgery. 4 - 6 treatments total. | $8,000 - $13,000 | | Stereotactic radiation and chemotherapy | 10 months | CT, radiation treatments, follow-up IV chemotherapy once every 3 weeks for 4 - 6 treatments. | $13,000-$15,000 | | Palliative-bisphosphonate/ supportive medications | 2 - 4 months | IV medications provided every 4 weeks. | $350 - $500 per treatment | | Other primary bone tumors | Pending tumor behavior and extent of disease | Pending further diagnostics, including CT, surgery, chemotherapy, or radiation therapy. | Pending recommendations |
The Data Engine – Where Expert Decisions Become Intelligence
Every clinical decision becomes data. Every data point makes the AI smarter.
1. Experts Teach the AI
Specialists review AI drafts. Every correction becomes a learning signal.
2. Knowledge Becomes Data
Clinical reasoning is structured into reusable training data.
3. Models Improve Automatically
Accuracy compounds with each new case — not with each new model.
"We turn expertise into data, data into intelligence,
and intelligence that improves itself."
One engine, many domains.
We start with veterinary medicine and extend the trusted pattern to other regulated fields.
AI-assisted veterinary consults, validated by board-certified specialists.
Structured intake and AI drafts for dental cases.
Drafting and research assistance with attorney oversight.
Future expansion into human healthcare with physician review.
Deploy the Global Trust OS on your terms—from SaaS dashboards to sovereign clouds.
The Expert Workspace
The zero-friction OS for specialists. A unified dashboard for rapid verification.
- Unified Case Command
- Rapid Verification
- Enterprise Security
The Headless API
Inject Board-Certified Reasoning directly into your existing stack.
- Standard REST
- Granular Control
- Event-Driven
Sovereign Cloud
The Trust OS. Private infrastructure completely isolated from the public cloud.
- Data Isolation
- Custom Models
- IP Protection
A Shared-Success Flywheel
We don't just sell software. We partner with specialist organizations to build a sustainable, revenue-generating ecosystem.
- ✓ Shared subscription revenue
- ✓ Defensible data IP for the org
- ✓ Reduced burnout for specialists
Streamline Specialist Work
Our platform makes reviewing cases 5x faster, freeing up experts to focus on high-value decisions.
Deploy AI Assistant to Clients
We launch a branded AI Assistant for your organization to handle routine intake and triage.
Revenue Share & Data Loop
Client subscriptions generate revenue for you, while expert edits continuously improve the AI's accuracy.
Ready to monetize your expertise?
If you represent a specialist organization, let's talk about how ConsultFlow can increase your efficiency and generate new revenue streams.
Partner with Us